STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
99
13F, latest reported quarter
What the filings say about NOMD
Insiders, 180 days
+$10.1M net bought
4 buyers
Nomad Foods insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Nomad Foods Ltd insiders bought a net $10.1M of stock across 7 Form 4 purchases and sales, with 4 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 15, 2026.
The trade is 6.9% of the 726,794 shares held after it.
1 other insider bought within 30 days.
99 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer BRISBY DOMINIC bought about $619.0K of NOMD on Aug 24, 2026; 1 other insider bought within 30 days and 99 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 14, 2026.
The trade is 7.7% of the 367,172 shares held after it.
1 other insider bought within 30 days.
99 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer BALDEW RUBEN bought about $335.2K of NOMD on Aug 19, 2026; 1 other insider bought within 30 days and 99 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 22.2% of the 676,794 shares held after it.
3 other insiders bought within 30 days.
99 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer BRISBY DOMINIC bought about $1.5M of NOMD on May 15, 2026; 3 other insiders bought within 30 days and 99 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 4.3% of the 338,882 shares held after it.
3 other insiders bought within 30 days.
99 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer BALDEW RUBEN bought about $143.0K of NOMD on May 14, 2026; 3 other insiders bought within 30 days and 99 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 85.5% of the 116,916 shares held after it.
3 other insiders bought within 30 days.
99 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ASHKEN IAN G H bought about $913.0K of NOMD on May 13, 2026; 3 other insiders bought within 30 days and 99 funds added in the latest 13F quarter.
7 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
NOMD planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
NOMD mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Invesco Food & Beverage ETF
$3.5M position · as of 2026-07-31
3.2%
Formidable ETF
$481.5K position · as of 2026-06-30
2.4%
VELA INTERNATIONAL FUND
$1.7M position · as of 2026-06-30
2.2%
ICON EQUITY INCOME FUND
$744.6K position · as of 2026-06-30
1.7%
Nicholas Limited Edition, Inc.
$5.0M position · as of 2026-07-31
1.5%
Thompson MidCap Fund
$809.1K position · as of 2026-05-31
1.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
4 insiders reported buying shares.
The record shows a net $10.1M bought by insiders over 180 days, 99 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Free cash flow, TTM NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
no equity line filed
Return on equity NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.1%
TTM net income over average of 2024-12-31 and 2025-12-31
Return on assets NOMD
FY Dec 2025
+2.1%
FY Dec 2024
+3.5%
FY Dec 2023
+3.0%
FY Dec 2022
+4.0%
FY Dec 2021
+3.1%
Dec 2025
+2.1%
Sep 2025
+3.1%
Jun 2025
+3.3%
Mar 2025
+3.5%
Dec 2024
+3.5%
Sep 2024
+3.1%
Jun 2024
+3.2%
Mar 2024
+2.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
fewer than four consecutive quarters of operating cash flow
FCF yield NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing NOMD
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
NOMD ranks highest on insider conviction (94th percentile) and risk and compliance (68th), and lowest on institutional and government (37th), among Food & Beverage peers.
Insider conviction
94
Inputs
Net Form 4 buying (codes P and S), 180d$10.1M · 96 pct, sector of 56
Insider buyers, 180d4 · 91 pct, sector of 56
Institutional and government
37
Inputs
Funds adding, latest quarter99 · 37 pct, sector of 79
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
68
Inputs
Short interest, % of float+2.3% · 68 pct, sector of 100
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Financial health, Growth, US patents
Profitability needs 2 of 4 inputs, 1 present: fewer than four consecutive quarters of operating income; no equity line filed
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
NOMD filings, in plain words
Are Nomad Foods insiders buying or selling NOMD?
In the 180 days to 2026-10-28, Nomad Foods insiders were net buyers, a net $10.1M across purchases and sales reported on Form 4, by 4 buyers.
Read the full summary
In the 180 days to 2026-10-28, Nomad Foods insiders were net buyers of NOMD, a net $10.1M across purchases and sales reported on Form 4 by 4 buyers. 2 different insiders reported purchases within the last 90 days, a cluster buy, which is rarer than a single purchase. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.